Wenjing Zheng Selected Research

Wenjing Zheng Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 02/2010
2	Infections 09/2023 - 08/2022
2	Primary Ovarian Insufficiency 02/2022 - 02/2010
2	Neuroinflammatory Diseases 01/2022 - 06/2021
2	Carcinogenesis 11/2021 - 10/2015
2	Inflammation (Inflammations) 10/2020 - 11/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2015 - 10/2015
2	Carcinoma (Carcinomatosis) 10/2015 - 06/2014
2	Myopia 01/2015 - 01/2014
1	Glioma (Gliomas) 05/2024
1	Glioblastoma (Glioblastoma Multiforme) 11/2023
1	Postoperative Hemorrhage 01/2023
1	Spinal Cord Compression 01/2023
1	Craniosynostoses (Craniosynostosis) 01/2022
1	Disease Resistance 01/2022
1	Exotropia (Exophoria) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Adenocarcinoma 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Hypoxia (Hypoxemia) 10/2020
1	Reperfusion Injury 10/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Insulin Resistance 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Esophagitis 01/2020
1	Esophageal Squamous Cell Carcinoma 01/2020
1	REM Sleep Behavior Disorder 12/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Dehydration (Water Stress) 01/2018
1	Breast Neoplasms (Breast Cancer) 03/2017
1	Synucleinopathies 07/2016
1	Prodromal Symptoms 07/2016
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Dry Eye Syndromes (Dry Eye Syndrome) 11/2015
1	Uterine Cervical Dysplasia 10/2015
1	Squamous Intraepithelial Lesions 10/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
4	Small Interfering RNA (siRNA)IBA 03/2017 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2016
3	Therapeutic UsesIBA 01/2023 - 01/2016
3	Peptides (Polypeptides)IBA 02/2022 - 06/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 01/2022
2	Long Noncoding RNAIBA 11/2021 - 01/2020
2	EcdysoneIBA 01/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2016 - 10/2015
2	RutheniumIBA 01/2016 - 10/2015
2	MicroRNAs (MicroRNA)IBA 11/2015 - 10/2015
2	polyoxometalateIBA 06/2014 - 06/2014
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 05/2024
1	Competitive Endogenous RNAIBA 09/2023
1	InterferonsIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	CytokinesIBA 01/2023
1	Phenylalanine (L-Phenylalanine)FDA Link 08/2022
1	jasmonic acid (jasmonate)IBA 08/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	CollagenIBA 01/2022
1	Muscle Proteins (Muscle Protein)IBA 01/2022
1	TropomodulinIBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	CalciumIBA 11/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2021
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 06/2021
1	QuercetinIBA 01/2021
1	Glycyrrhetinic Acid (Po 12)IBA 10/2020
1	Adenosine Diphosphate (ADP)IBA 01/2020
1	AdiponectinIBA 01/2020
1	AldosteroneIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Circular RNAIBA 01/2020
1	SteroidsIBA 01/2020
1	Uric Acid (Urate)IBA 12/2018
1	Antimicrobial PeptidesIBA 01/2018
1	peptidoglycan recognition proteinIBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	ecdysone receptorIBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2017
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 03/2017
1	Metal-Organic FrameworksIBA 03/2017
1	TubulinIBA 02/2016
1	bis(bipyridyl)ruthenium(II)IBA 01/2016
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2016
1	Laminin ReceptorsIBA 01/2016
1	2,2'-Dipyridyl (2,2 Bipyridine)IBA 01/2016
1	Fibroblast Growth Factor 10IBA 11/2015
1	MucinsIBA 11/2015
1	Cisplatin (Platino)FDA LinkGeneric 10/2015

Therapy/Procedure

5	Therapeutics 01/2023 - 06/2012
2	Drug Therapy (Chemotherapy) 01/2022 - 02/2016
1	Radiotherapy 01/2023
1	Immunotherapy 01/2023
1	Urinary Catheters 01/2023
1	Length of Stay 01/2023
1	Enhanced Recovery After Surgery 01/2023
1	Hepatectomy 08/2019